Adma Biologics (ADMA) EBITDA Margin Growth (1y) (2012 - 2026)
Adma Biologics (ADMA) EBITDA Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1,049.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1,238.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.76 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -1,651.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2,002.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,091.00 |
| 10 | Adma Biologics | 2.13 Bn | 2.00 Bn | 86.28 Mn | 708.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 708.00 |
| Dec 31, 2025 | 1,249.00 |
| Sep 30, 2025 | 493.00 |
| Jun 30, 2025 | -149.00 |
| Mar 31, 2025 | 373.00 |
| Dec 31, 2024 | 1,334.00 |
| Sep 30, 2024 | 2,518.00 |
| Jun 30, 2024 | 3,736.00 |
| Mar 31, 2024 | 2,808.00 |
| Dec 31, 2023 | 3,138.00 |
| Sep 30, 2023 | 3,057.00 |
| Jun 30, 2023 | 1,145.00 |
| Mar 31, 2023 | 4,948.00 |
| Dec 31, 2022 | 1,186.00 |
| Sep 30, 2022 | 4,714.00 |
| Jun 30, 2022 | 7,515.00 |
| Mar 31, 2022 | 4,358.00 |
| Dec 31, 2021 | 9,940.00 |
| Sep 30, 2021 | 6,449.00 |
| Jun 30, 2021 | 13,250.00 |